Difference between revisions of "Morphoea"
Jump to navigation
Jump to search
(Page created) |
|||
(2 intermediate revisions by 2 users not shown) | |||
Line 14: | Line 14: | ||
==Guidance== | ==Guidance== | ||
− | Establish cause and discuss with medical officer. May be acceptable if mild and not associated with systemic autoimmune disease. | + | Establish cause and discuss with medical officer. May be acceptable for BM only if mild and not associated with systemic autoimmune disease. |
Inform transplant centre at CT. | Inform transplant centre at CT. | ||
Line 22: | Line 22: | ||
==Version== | ==Version== | ||
− | Version 1, Edition | + | Version 1, Edition 2 |
====Date of Last Update==== | ====Date of Last Update==== | ||
− | + | 1 June 2016 |
Latest revision as of 16:41, 1 June 2016
Contents
Acceptability at Recruitment
QUALIFIED
Acceptability at CT / Work-Up
QUALIFIED
Individual at Risk
Recipient
Explanation of Condition
Skin condition causing localised thickening of the skin. Likely autoimmune in nature.
See also Morphoea
Guidance
Establish cause and discuss with medical officer. May be acceptable for BM only if mild and not associated with systemic autoimmune disease.
Inform transplant centre at CT.
Pseudonyms or Related Conditions
Localised scleroderma
Version
Version 1, Edition 2
Date of Last Update
1 June 2016